Abstract:Background: Ginsenosides were considered as the main bioactive constituents in Ginseng Radix et Rhizoma (GRR). However, because of high polarity, ginsenosides were hard to be absorbed in human or animal gastrointestinal tract after oral administration. Up to now, very few studies have been performed in the area of simultaneous pharmacokinetic analysis of multiple ginsenosides with similar structures. Purpose: This research aimed to compare the different absorption characteristics of ginsenosides and aglycones between GRR and Baoyuan decoction (BYD), one of formulas containing GRR, with the same dosage. Methods: GRR and BYD extracts were prepared with same method. A single dose of GRR and BYD extracts were administrated to rats through gavage, respectively. A solid phase extraction method was used to purify the plasma samples. An ultra-fast liquid chromatography coupled with tandem mass spectrometry (UFLC-MS/MS) method was established and fully validated for quantitative analysis. In addition, an in vitro incubation of GRR extract with intestinal flora was conducted to confirm the influence of gut microbiota to the absorption of ginsenosides and aglycones. Results: The results of incubation experiments showed that most high polar ginsenosides could transform to less polar ginsenosides via intestinal flora. The validated UFLC-MS/MS method was sensitive and precise to simultaneously analyze the pharmacokinetics of multiple ginsenosides. After oral administration of GRR and BYD extracts, the pharmacokinetic results showed that a total of 11 ginsenosides and 2 aglycones could be quantitatively determined in both groups of plasma. Besides, five compounds were only quantified in BYD extract group. In addition, another 21 ginsenosides could be qualitatively measured. Conclusion: The results indicated significant pharmacokinetic differences of ginsenosides and aglycones between two groups. For most less polar ginsenosides who had better bioactivity, the preparation was possessed of higher plasma concentrations. The comparative results indicated that some co-existing compounds in BYD might inhibit the exocytosis of ginsenosides. Moreover, what is worth mentioning, some ginsenosides and aglycones could only be detected and quantified a few hours later after administration to rats. Combining with the in vitro incubation experiments, the results demonstrated that transformation of ginsenosides in gastrointestinal tract via intestinal flora existed during absorption.

Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography-tandem mass spectrometry.

Identification of metabolites of ganoderic acid D by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Pharmacokinetic Studies of Ganoderic Acids from the Lingzhi or Reishi Medicinal Mushroom, Ganoderma Lucidum (agaricomycetes), by LC-MS/MS.

Structural Characterization of Minor Metabolites and Pharmacokinetics of Ganoderic Acid C2 in Rat Plasma by HPLC Coupled with Electrospray Ionization Tandem Mass Spectrometry

Characterization of the Chemical Constituents in Da-Huang-Gan-Cao-Tang by Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Tandem Mass Spectrometry and Liquid Chromatography Coupled with Ion Trap Mass Spectrometry

Metabolite identification of crude extract from Ganoderma lucidum in rats using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry

Structural Identification of the Metabolites of Ganoderic Acid B from Ganoderma Lucidum in Rats Based on Liquid Chromatography Coupled with Electrospray Ionization Hybrid Ion Trap and Time-Of-Flight Mass Spectrometry

Rapid Determination of Diverse Ganoderic Acids in Ganoderma Using UPLC–MS/MS

Determination of ganoderic acids in rat plasma after oral administration of total triterpenoids from Ganoderma lucidum

Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography.

Rapid Simultaneous Determination of Four Ganoderic Acids in Ganoderma (chinese Name: Lingzhi ) by Direct Infusion–Multiple Reaction Monitoring Cubed

Influence of different cultivation methods on ganoderic acid synthesis and solid-state fermentation condition optimization

[Analysis on ingredients and metabolites of Gegen Decoction absorbed into blood based on UHPLC-Q-TOF-MS]

Pharmacokinetics Comparison of 15 Ginsenosides and 3 Aglycones in Ginseng Radix Et Rhizoma and Baoyuan Decoction Using Ultra-Fast Liquid Chromatography Coupled with Triple Quadrupole Tandem Mass Spectrometry.

A Sensitive LC/MS/MS Method for the Determination of Glycyrrhetic Acid in Human Plasma and Application to Pharmacokinetic Study

Different absorption and metabolism of ginsenosides after the administration of total ginsenosides and decoction of <scp> <i>Panax ginseng</i> </scp>

Identification and characterization of chemical constituents in Mahuang Guizhi Decoction and their metabolites in rat plasma and brain by UPLC-Q-TOF/MS

Screening and Analysis of the Marker Components in Ganoderma lucidum by HPLC and HPLC-MSn with the Aid of Chemometrics

Quantitative Determination of Ganoderic Acid H in SunRecome~ by Reversed-phase High Performance Chromatography

HPLC Method for the Determination and Pharmacokinetic Studies of Four Triterpenoids in Rat Plasma after Oral Administration of Ganoderma Lucidum Extract.